ClinicalTrials.govpublic full text
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
relapsed or refractory systemic light chain amyloidosis, mln9708, amyloidosis, light chain, ixazomib, tourmaline al1, drug therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807089
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.